Lincoln Capital Corp Abb Vie Inc. Transaction History

Lincoln Capital Corp

$240 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $17,580 - $20,031	110 Added 7.46%	1,585 $288,000
Q4 2023 Jan 18, 2024	SELL	$137.6 - $154.97 $2,064 - $2,324	-15 Reduced 1.01%	1,475 $228,000
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $41,412 - $47,941	-310 Reduced 17.22%	1,490 $222,000
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $18,153 - $22,591	-137 Reduced 7.07%	1,800 $242,000
Q1 2023 Apr 20, 2023	SELL	$144.61 - $166.54 $144,031 - $165,873	-996 Reduced 33.96%	1,937 $308,000
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $82,986 - $99,522	-600 Reduced 16.98%	2,933 $0
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $75,560 - $86,662	-563 Reduced 13.75%	3,533 $474,000
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $101,838 - $129,470	740 Added 22.05%	4,096 $627,000
Q1 2022 Apr 19, 2022	BUY	$131.98 - $163.75 $60,182 - $74,670	456 Added 15.72%	3,356 $544,000
Q2 2021 Jul 22, 2021	SELL	$105.21 - $117.21 $45,871 - $51,103	-436 Reduced 13.07%	2,900 $327,000
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $244,762 - $327,528	3,336 New	3,336 $328,000
Q1 2020 Apr 16, 2020	SELL	$64.5 - $97.79 $404,995 - $614,023	-6,279 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $64,556 - $80,773	-895 Reduced 12.48%	6,279 $556,000
Q3 2019 Nov 05, 2019	SELL	$62.98 - $75.72 $10,580 - $12,720	-168 Reduced 2.29%	7,174 $543,000
Q2 2019 Jul 12, 2019	SELL	$65.7 - $83.98 $46,187 - $59,037	-703 Reduced 8.74%	7,342 $534,000
Q1 2019 Apr 11, 2019	SELL	$77.14 - $90.79 $154,897 - $182,306	-2,008 Reduced 19.97%	8,045 $648,000
Q4 2018 Jan 22, 2019	SELL	$77.85 - $96.01 $36,044 - $44,452	-463 Reduced 4.4%	10,053 $927,000
Q3 2018 Oct 10, 2018	SELL	$88.91 - $98.84 $2.02 Million - $2.24 Million	-22,703 Reduced 68.34%	10,516 $995,000
Q2 2018 Jul 26, 2018	SELL	$89.78 - $106.23 $133,772 - $158,282	-1,490 Reduced 4.29%	33,219 $3.08 Million
Q1 2018 Apr 12, 2018	SELL	$92.01 - $123.21 $1.02 Million - $1.36 Million	-11,074 Reduced 24.19%	34,709 $3.29 Million
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $320,445 - $351,395	-3,578 Reduced 7.25%	45,783 $4.43 Million
Q3 2017 Oct 18, 2017	BUY	$69.85 - $89.22 $3.45 Million - $4.4 Million	49,361	49,361 $4.39 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln Capital Corp with notifications on news.

Account